School-Based Preventive Asthma Care Technology: A Randomized Control Trial Using a Novel Technology to Improve Adherence
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 99
- 试验地点
- 1
- 主要终点
- Average Number of Symptom-free Days Over 14 Days; (Symptom-free Days Are Averaged Over 4 Bi-monthly Follow-ups)
研究概览
简要总结
The goal of this new translational project is to test the feasibility and effectiveness of implementing school-based directly observed therapy of preventive asthma medications in a real-world setting, using state-of-the-art web-based technology for systematic screening, electronic report generation, and communication between nurses, caregivers, and primary care providers. With the use of a novel method to improve adherence and subsequently reduce morbidity, the investigators hypothesize that this novel adaptation of school-based asthma care will; 1) be feasible and acceptable among this population and among school and community stakeholders, and 2) yield reduced asthma morbidity (symptom-free days, absenteeism, and emergency room / urgent care use for asthma care). The investigators anticipate that enhancing preventive healthcare for young urban children with asthma through partnerships with the schools using a novel technology will yield improved health, prevention of suffering, decreased absenteeism from school, and reduced healthcare costs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 3 Years 至 10 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •(all 4 criteria must be met):
- •Physician-diagnosed asthma (based on parent report).
- •Persistent asthma (criteria based on NHLBI guidelines). Any 1 of the following:
- •An average of >2 days per week with asthma symptoms
- •>2 days per week with rescue medication use
- •>2 days per month with nighttime symptoms
- •≥2 episodes of asthma during the past year that have required systemic corticosteroids
- •Age ≥3 and ≤10 years.
- •Attending school in participating Rochester City School District preschools or elementary schools.
排除标准
- •Inability to speak and understand English. (*Parents unable to read will be eligible, and all instruments will be given verbally.)
- •No access to a working phone for follow-up surveys (either at the subject's home or an easily accessible alternate phone number).
- •Family planning to leave the school district within fewer than 6 months.
- •The child having other significant medical conditions, including congenital heart disease, cystic fibrosis, or other chronic lung disease, that could interfere with the assessment of asthma-related measures.
- •Children in foster care or other situations in which consent cannot be obtained from a guardian.
研究组 & 干预措施
School-Based Medication Group
For children assigned to the School-Based Medication group, an asthma coordinator will send the child's primary care physician a report indicating the child's asthma symptoms, and will recommend that the child receive a preventive asthma medication at school. If the child's doctor agrees, the preventive asthma medication will be delivered to the child's school and to his/her home by a local pharmacy. The child's school nurse will begin directly observed therapy of the preventive asthma medication at school, and will routinely assess the child's asthma symptoms throughout the school year.
干预措施: School-Based Medication Delivery (Other)
Usual Care Group
Children in the Usual Care group will not receive preventive medications delivered at school. These children will continue to receive all of their asthma care from their parents and primary care physicians.
结局指标
主要结局
Average Number of Symptom-free Days Over 14 Days; (Symptom-free Days Are Averaged Over 4 Bi-monthly Follow-ups)
时间窗: Average number of days, over 2 weeks, throughout the school year
The primary outcome is asthma morbidity between groups. We will measure asthma morbidity by looking at the average number of symptom-free days, over 2 weeks, at each bi-monthly follow-up time point over the school year. Number of days without asthma symptoms will be reported by the child's caregiver.
次要结局
- Cost Effectiveness(one year)
- Feasibility and Acceptability(one year)
研究者
Jill Halterman
Associate Professor of Pediatrics
University of Rochester